About Christopher Dunn
Christopher Dunn is a director at Alzheon.
Christopher Dunn first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Dunn in the role, so the role may have started earlier or lasted longer.
Alzheon, Inc.
Director
2023 – 2026 · Framingham, MA
Develops investigational medicines for people with Alzheimer’s and other neurodegenerative disorders.
Key Colleagues at Startups
The people Christopher Dunn works with at each company, as listed on that company's latest Form D.
Alzheon, Inc. · Form D, Sep 10, 2026
Neil Flanzraich
Executive Chairman of the Board of Directors
Diane Jorkasky, M.D.
Director
JD
John Hey, Ph.D.
Chief Scientific Officer
SD
Susan Abushakra, M.D.
Chief Medical Officer
MS
Muneer Satter
Director
Jordan Heller
Director
AM
Aidan Power, MRCPsych
Chief Development Officer
Gino Santini
Director
Kenneth Mace
Chief Financial Officer
MD
Martin Tolar, M.D., Ph.D.
Founder, President & CEO, director
Adem Albayrak
Chief Data & AI Officer